Russia’s Sputnik V vaccine was found to be 91.6 per cent effective against symptomatic Covid-19 in trial results published Tuesday, as the number of vaccinations administered worldwide passed 100 million.
But none of the world´s 29 poorest countries has formally started mass vaccination drives, while the richest nations — despite finger-pointing over delivery delays — have provided more than two-thirds of the jabs administered so far.
The United Arab Emirates (UAE) has initiated clinical trials of Russia’s sputnik vaccine for Covid-19 as the number of cases surge in the country.
Additionally, The Drug Regulatory Authority of Pakistan has granted approval for emergency use of the Russian anti-coronavirus vaccine Gam-COVID-Vac, commonly known as Sputnik V.
Russian vaccine -The sputnik vaccine V
Misgivings over transparency issues around Sputnik V which was rolled out in Russia and other countries before the Phase 3 trial results were published — could be set aside after number-crunching published by The Lancet journal placed the vaccine among top performers alongside those of Pfizer/BioNTech and Moderna.
Data from the first two phases of the trial had shown that the subjects receiving Sputnik V vaccine had a stable humoral as well as cellular immune response and no serious adverse events were noted.
Sputnik V was developed by the Ministry of Health of the Russian Federation’s Gamaleya Research Institute of Epidemiology and Microbiology.
……………………………………….Leave a comment